Search research articles
Contact Us
Filters
Showing results (151-160 of 459) with videos related to
Page
of 46
Sort By:
Expert Review of Anticancer Therapy
|
May 15, 2023
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer
Giacomo Nuvola, Matteo Santoni, Mimma Rizzo, et al.
Immunotherapy
|
November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis
Matteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
Current Drug Targets
|
December 10, 2015
An Overview of Emerging Immunotargets of Genitourinary Tumors
Rodolfo Montironi, Matteo Santoni, Liang Cheng, et al.
Biomed Research International
|
June 28, 2014
CXC and CC chemokines as angiogenic modulators in nonhaematological tumors
Matteo Santoni, Sergio Bracarda, Massimo Nabissi, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting
Halima Abahssain, Amine Souadka, Rania Alem, et al.
Current Drug Metabolism
|
February 26, 2019
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy
Alessia Cimadamore, Marina Scarpelli, Matteo Santoni, et al.
Recenti Progressi in Medicina
|
May 22, 2015
[Treatment of pancreatic cancer. Actuality and perspective]
Alessandro Bittoni, Kalliopi Andrikou, Andrea Lanese, et al.
Cancer Treatment Reviews
|
September 28, 2013
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
Roberto Iacovelli, Daniele Alesini, Antonella Palazzo, et al.
Frontiers in Oncology
|
January 10, 2018
Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression
Alessia Cimadamore, Silvia Gasparrini, Roberta Mazzucchelli, et al.
European Urology
|
March 8, 2016
Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4
Francesco Piva, Matteo Santoni, Marina Scarpelli, et al.
Page
of 46
Search research articles
Search
Showing results (151-160 of 459) with videos related to
Sort By:
Page
of 46
Expert Review of Anticancer Therapy
|
May 15, 2023
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer
Giacomo Nuvola, Matteo Santoni, Mimma Rizzo, et al.
Immunotherapy
|
November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis
Matteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
Current Drug Targets
|
December 10, 2015
An Overview of Emerging Immunotargets of Genitourinary Tumors
Rodolfo Montironi, Matteo Santoni, Liang Cheng, et al.
Biomed Research International
|
June 28, 2014
CXC and CC chemokines as angiogenic modulators in nonhaematological tumors
Matteo Santoni, Sergio Bracarda, Massimo Nabissi, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting
Halima Abahssain, Amine Souadka, Rania Alem, et al.
Current Drug Metabolism
|
February 26, 2019
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy
Alessia Cimadamore, Marina Scarpelli, Matteo Santoni, et al.
Recenti Progressi in Medicina
|
May 22, 2015
[Treatment of pancreatic cancer. Actuality and perspective]
Alessandro Bittoni, Kalliopi Andrikou, Andrea Lanese, et al.
Cancer Treatment Reviews
|
September 28, 2013
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
Roberto Iacovelli, Daniele Alesini, Antonella Palazzo, et al.
Frontiers in Oncology
|
January 10, 2018
Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression
Alessia Cimadamore, Silvia Gasparrini, Roberta Mazzucchelli, et al.
European Urology
|
March 8, 2016
Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4
Francesco Piva, Matteo Santoni, Marina Scarpelli, et al.
Page
of 46